Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |